Inventiva (IVEVF) Total Current Liabilities (2018 - 2025)
Inventiva (IVEVF) posted Total Current Liabilities of $90.1 million for Q4 2025, up 36.12% on a QoQ basis from $66.2 million in Q2 2025, and down 30.18% year-over-year from $129.0 million in Q4 2024.
Analysis
Inventiva (IVEVF) Total Current Liabilities (2018 - 2025) Analysis & Trends
Inventiva has reported Total Current Liabilities for 8 years, with the latest figure at $90.1 million in Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 30.18% year-over-year to $90.1 million in Q4 2025; TTM through Dec 2025 was $90.1 million, a 30.18% decrease from a year earlier, with the FY2025 full-year figure at $90.1 million, down 30.18% from the prior year.
- Total Current Liabilities was $90.1 million for Q4 2025 at Inventiva, up from $66.2 million in the prior quarter.
- The five-year high for Total Current Liabilities was $129.0 million in Q4 2024, with the low at $20460.9 in Q2 2024.
- Average Total Current Liabilities over 5 years is $45.5 million, with a median of $31.3 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities slumped 99.95% in 2024, then jumped 323308.14% in 2025.
- Over 5 years, Total Current Liabilities stood at $26.1 million in 2021, then gained by 19.81% to $31.3 million in 2022, then jumped by 72.29% to $54.0 million in 2023, then jumped by 139.06% to $129.0 million in 2024, then tumbled by 30.18% to $90.1 million in 2025.
- The last three Total Current Liabilities figures came in at $90.1 million (Q4 2025), $66.2 million (Q2 2025), and $129.0 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 32.65 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | 37.11 Bn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | 354.06 Mn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 1.31 Bn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 607.80 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 90.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 90.07 Mn |
| Jun 30, 2025 | 66.17 Mn |
| Dec 31, 2024 | 129.01 Mn |
| Jun 30, 2024 | 20,460.86 |
| Dec 31, 2023 | 53.97 Mn |
| Jun 30, 2023 | 41.16 Mn |
| Dec 31, 2022 | 31.32 Mn |
| Jun 30, 2022 | 25.66 Mn |
| Dec 31, 2021 | 26.14 Mn |
| Jun 30, 2021 | 17.91 Mn |
| Mar 31, 2021 | 19.38 Mn |
| Dec 31, 2020 | 16.58 Mn |
| Jun 30, 2020 | 27.76 Mn |
| Dec 31, 2019 | 15.35 Mn |
| Dec 31, 2018 | 17.21 Mn |